Tanoue et al. found that in the prostate cancer xenotransplantation model, CAd-VECPDL1, a type of OV expressing PD-L1 blocking small antibodies, boosted the anti-tumor activity of CAR-T cells targeting HER2 [209]. This evidence concerns the gene CD274 and neoplasm.